Trial
NCT05157997
Transplantation of Deceased Donors With COVID-19 Into COVID-19 Negative Recipients Utilizing Casirivimab and Imdevimab Antibody Cocktail
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Northwell Health
Collaborators
Regeneron Pharmaceuticals
Condition
COVID-19
Intervention
Casirivimab and Imdevimab Antibody Cocktail
Why stopped
New information regarding COVID-19
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-22